The angiotensin II type 2 receptor in renal disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 1, 2010, Pages 37-41

  Wenzel, Ulrich Otto ^a   Krebs, Christian ^a   Benndorf, Ralf ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Angiotensin; AT2 receptor; Fibrosis; Inflammation; Kidney

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST;

ALDOSTERONE RELEASE; APOPTOSIS; BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CHRONIC KIDNEY DISEASE; DISEASE COURSE; FIBROSIS; HORMONE ACTION; HUMAN; HYPERTROPHY; KIDNEY DEVELOPMENT; KNOCKOUT MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACODYNAMICS; RENAL PROTECTION; REVIEW; SODIUM TRANSPORT; VASOCONSTRICTION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 77749254986     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309347787     Document Type: Review

References (28)

1. Coresh J., Wei GL, McQuillan G. et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001 ; 161: 1207-1216.
2. Wenzel U. Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention? Kidney Int 2007 ; 71: 374-376.
3. Wenzel UO Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies. Contrib Nephrol 2001 ; 135: 200-211.
4. Suzuki K., Han GD, Miyauchi N. et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 2007 ; 170: 1841-1853.
5. Reudelhuber TL The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous. Hypertension 2005 ; 46: 1261-1262.
6. Benndorf R., Boger RH, Ergun S., Steenpass A., Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 2003 ; 93: 438-447.
7. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998 ; 83: 1182-1191.
8. Wolf G., Wenzel U., Burns KD et al. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 2002 ; 61: 1986-1995.
9. Wolf G., Ziyadeh FN, Thaiss F. et al. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997 ; 100: 1047-1058.
10. Niimura F., Kon V., Ichikawa I. The renin-angiotensin system in the development of the congenital anomalies of the kidney and urinary tract. Curr Opin Pediatr 2006 ; 18: 161-166.
11. Schütz S., Le Moullec JM, Corvol P., Gasc JM Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996 ; 149: 2067-2079.
12. Nishimura H., Yerkes E., Hohenfellner K. et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999 ; 3: 1-10.
13. Gross V., Obst M., Luft FC Insights into angiotensin II receptor function through AT2 receptor knockout mice. Acta Physiol Scand 2004 ; 181: 487-494.
14. Siragy HM, Inagami T., Ichiki T., Carey RM Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999 ; 96: 6506-6510.
15. Pettersson-Fernholm K., Frojdo S., Fagerudd J. et al. The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patients. Kidney Int 2006 ; 69: 1880-1884.
16. Vazquez E., Coronel I., Bautista R. et al. Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. Am J Physiol Renal Physiol 2005 ; 288: F207-13.
17. Cao Z., Bonnet F., Candido R. et al. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 2002 ; 13: 1773-1787.
18. Esteban V., Lorenzo O., Ruperez M. et al. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004 ; 15: 1514-1529.
19. Anderson S., Rennke HG, Brenner BM Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986 ; 77: 1993-2000.
20. Benndorf RA, Krebs C., Hirsch-Hoffmann B. et al. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int 2009 ; 75: 1039-1049.
21. Ma J., Nishimura H., Fogo A. et al. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998 ; 53: 937-944.
22. Hashimoto N., Maeshima Y., Satoh M. et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 2004 ; 286: F516-25.
23. Ozono R., Wang ZQ, Moore AF et al. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997 ; 30: 1238-1246.
24. Tejera N., Gomez-Garre D., Lazaro A. et al. Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol 2004 ; 164: 1817-1826.
25. Messerli FH, Bangalore S., Ram VS Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 ; 359: 426-427.
26. Azizi M., Menard J., Bissery A. et al. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. J Am Soc Nephrol 2004 ; 15: 3126-3133.
27. Wan Y., Wallinder C., Plouffe B. et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004 ; 47: 5995-6008.
28. Kaschina E., Grzesiak A., Foryst-Ludwig A. et al. Angiotensin II type 2 receptor stimulation. A novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 2008 ; 118: 2523-2532.